Study: mRNA vaccine is associated with decreased SARS-CoV-2 viral load in individuals with breakthrough infection, suggesting a role in suppressing onward transmission
30 Mar, 2021 | 03:25h | UTC
Commentaries on Twitter
A study in @NatureMedicine reports that breakthrough SARS-CoV-2 infections occurring 12 or more days after the first dose of the Pfizer-BioNTech vaccine had lower viral loads, suggesting the vaccine might reduce infectiousness. https://t.co/yskN9lgiwr pic.twitter.com/LQVESgRjZz
— Nature Research (@nresearchnews) March 29, 2021
(Thread – Click for more)
New @NatureMedicine: The concern about asymptomatic transmission addressed in nearly 5,000 people after 1st dose of mRNA vaccine (~2 -5 wks). Viral load markedly reduced (high Ct). Supports vaccine effect for blocking or strongly reducing chance of spreadhttps://t.co/mmJmZPZfHK pic.twitter.com/0TTf4cFZed
— Eric Topol (@EricTopol) March 29, 2021